Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 2212-2220, October 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bridge, M. F.
Right arrow Articles by Melamed, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bridge, M. F.
Right arrow Articles by Melamed, M. R.

Leukocyte Chromosome Abnormalities in Advanced Nonhematopoietic Cancer

Mary F. Bridge1 and Myron R. Melamed2

Cytology Service, Memorial Hospital for Cancer and Allied Diseases, New York, New York 10021

Cytogenetic abnormalities have previously been identified in peripheral blood leukocyte cultures of patients with advanced cancer, usually after treatment with drugs or irradiation. In this study, karyotypes were done on leukocyte cultures from 25 patients with advanced malignant tumors of various types. Patients were grouped according to type and amount of drug and/or radiotherapy received, and chromosome abnormalities were compared in these groups.

Untreated patients and those receiving smaller amounts of chemotherapy differed little from normal controls. One patient who had received larger amounts of anticancer drugs, and most of those who had received radiotherapy, particularly high-voltage modalities, had a larger number of chromosome abnormalities. It is concluded that leukocyte chromosome abnormalities seen in patients dying with far-advanced cancer are due to therapy and are not otherwise related to the stage of their disease.

1 Fellow, Cytology Service.

2 Attending Pathologist and Acting Chief Cytology Service. To whom requests for reprints should be addressed, at Memorial Hospital for Cancer and Allied Disease, 444 East 68th Street, New York, N. Y. 10021.

Received 4/26/72. Accepted 6/23/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.